COVID-19 Vaccines

Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19.

Also Known As:

2019 nCoV Vaccine; 2019 nCoV Vaccines; COVID 19 Vaccines; COVID 19 Virus Vaccine; COVID 19 Virus Vaccines; Coronavirus Disease 19 Vaccine; Coronavirus Disease 19 Vaccines; SARS CoV 2 Vaccine; SARS CoV 2 Vaccines; Vaccine, 2019-nCoV; Vaccine, COVID 19; Vaccine, COVID-19; Vaccine, COVID-19 Virus; Vaccine, COVID19; Vaccine, COVID19 Virus; Vaccine, Coronavirus Disease-19; Vaccine, SARS-CoV-2; Vaccine, SARS2; Vaccines, 2019-nCoV; Vaccines, COVID-19; Vaccines, COVID-19 Virus; Vaccines, COVID19; Vaccines, COVID19 Virus; Vaccines, Coronavirus Disease-19; Vaccines, SARS-CoV-2; Vaccines, SARS2; Virus Vaccine, COVID-19; Virus Vaccine, COVID19; Virus Vaccines, COVID-19; Virus Vaccines, COVID19; 2019 Novel Coronavirus Vaccine; 2019 Novel Coronavirus Vaccines; 2019-nCoV Vaccine; 2019-nCoV Vaccines; COVID 19 Vaccine; COVID-19 Vaccine; COVID-19 Virus Vaccine; COVID-19 Virus Vaccines; COVID19 Vaccine; COVID19 Vaccines; COVID19 Virus Vaccine; COVID19 Virus Vaccines; Coronavirus Disease 2019 Vaccine; Coronavirus Disease 2019 Vaccines; Coronavirus Disease 2019 Virus Vaccine; Coronavirus Disease 2019 Virus Vaccines; Coronavirus Disease-19 Vaccine; Coronavirus Disease-19 Vaccines; SARS Coronavirus 2 Vaccines; SARS-CoV-2 Vaccine; SARS-CoV-2 Vaccines; SARS2 Vaccine; SARS2 Vaccines

Complex Mixtures: 1947
- Biological Products
  - Vaccines: 128365
    - Viral Vaccines: 473
      - COVID-19 Vaccines: 8432

Lorena Benathar Ballod Tavares Selected Research

Lorena Benathar Ballod Tavares Research Topics

Disease

Drug/Important Bio-Agent (IBA)